How much is Chordline Health worth in 2026?

Chordline Health has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Chordline Health raised?

Chordline Health has raised N/A in total funding across 1 funding rounds.

Chordline Health

Enterprise Systems (Healthcare)

Chordline Health valuation and funding history | Last updated: February 19, 2025 | 1 funding rounds

Current Valuation

N/A

As of February 19, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 19, 2025	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Chordline Health is currently valued at N/A as of February 19, 2025.

Track Chordline Health Valuation Updates

Get notified when Chordline Health raises new funding or valuation changes

Explore More Data

Detailed analysis for Chordline Health

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Chordline Health's valuation history, funding rounds, and growth metrics.

No credit card required

What is Chordline Health Worth in 2026?

Chordline Health is a leading private company in the Enterprise Systems (Healthcare) sector. Track Chordline Health's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Chordline Health Valuation is Determined

Private company valuations like Chordline Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.